Skip to content

treatment of enlargement of prostatic by Closing the feeder vessels

Evaluation of efficacy and complications of prostatic arterial embolization in the treatment of BPH

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015100318457N2
Enrollment
12
Registered
2016-06-16
Start date
2015-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia. Hyperplasia of Prostate

Interventions

Prostatic Artery Embolization using polyvinyl guided by Angiographic catheter into the artery of the Prostate.
Treatment - Other
Prostatic Artery Embolization using polyvinyl guided by Angiographic catheter into the artery of the Prostate

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
55 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Men aged over 60 years having benign prostatic hyperplasia; no respond to medical treatment after 6 months, having sexual dysfunction, having maximum flow rate (Qmax) less than 12 mm/s in urine; ?;acute urinary retention . Exclusion criteria: malignancy; tortuosity and atherosclerotic iliac artery; having any indication for renal surgery such as hematuria, bladder diverticula, stones

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Q max. Timepoint: befor intrvention and 1,3,6 months after intervention. Method of measurement: uroflowmetry.;IPSS. Timepoint: befor intrvention and 1,3,6 months after intervention. Method of measurement: Questionnaire.;Prostat size. Timepoint: befor intrvention and 1,3,6 months after intervention. Method of measurement: Sonography.;PSA level. Timepoint: befor intrvention and 1,3,6 months after intervention. Method of measurement: lab.

Secondary

MeasureTime frame
Contrast media side effectS. Timepoint: during procedure and after 24 hours. Method of measurement: question from patient and clinical examination.;Sexual dysfunction. Timepoint: 6 months after surgery. Method of measurement: question from patients.;Dont response to embolization and need to surgery. Timepoint: after 6 months. Method of measurement: question from patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Hossein Jalali

Advanced And Inteventional Radiology Research Center

Amirjalali51@yahoo.com+98 21 6658 1579

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026